LONDON, March 30, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces positive ...
WOODBURY, Minn., March 23, 2026 /PRNewswire/ -- Kindeva, a global CDMO and drug delivery innovator, commemorates 70 years today, since the invention of the pressurized metered dose inhaler (pMDI), a ...
AstraZeneca will discontinue the production of PULMICORT® (budesonide) 100 and 200 µg/dose HFA pMDI (pressurised metered dose inhaler) due to complex manufacturing issues related to technical aspects ...
Luforbec 100µg/6µg pMDI is indicated for adult asthma and COPD treatment, where the use of an inhaled corticosteroid and long-acting beta2-agonist (ICS/LABA) is suitable. With the same active ...
August 18, 2010 — Once-daily budesonide/formoterol administered by pressurized metered-dose inhaler (pMDI) achieves better maintenance of pulmonary function vs once-daily pMDI budesonide in 6- to ...
LONDON, UK, 7 March 2011 - SkyePharma PLC (LSE: SKP) today announces that AstraZeneca has informed it of a decision to discontinue production of PULMICORT (budesonide) 100 and 200 µg/dose HFA pMDI ...
LONDON and RALEIGH, N.C., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces ...
The Virginia Department of Fire Programs has banned the use of oriented strand board (OSB) containing poly-methylene diphenyl diisocyanate (PMDI) during live fire training, the agency announced ...
MUMBAI, India, March 19, 2026 /PRNewswire/ -- AeroDel Technology Innovations Pvt. Ltd., a Mumbai-based respiratory medical device company, announces an exclusive licensing arrangement with Zydus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results